Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina Tbk's other current liabilities for the quarter that ended in Jun. 2026 was Rp141,665 Mil.
PT Medikaloka Hermina Tbk's quarterly other current liabilities
declined
from Dec. 2025 (Rp220,664 Mil) to Mar. 2026 (Rp127,360 Mil) but then
increased
from Mar. 2026 (Rp127,360 Mil) to Jun. 2026 (Rp141,665 Mil).
PT Medikaloka Hermina Tbk's annual other current liabilities
increased
from Dec. 2023 (Rp176,898 Mil) to Dec. 2024 (Rp201,602 Mil) and
increased
from Dec. 2024 (Rp201,602 Mil) to Dec. 2025 (Rp220,664 Mil).
PT Medikaloka Hermina Tbk Other Current Liabilities Related Terms
PT Medikaloka Hermina Tbk Other Current Liabilities Historical Data
* Premium members only.
The historical data trend for PT Medikaloka Hermina Tbk's Other Current Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk Other Current Liabilities Chart
PT Medikaloka Hermina Tbk Other Current Liabilities Calculation
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
What does a Other Current Liabilities of Rp141,665 Mil mean?
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Other Current Liabilities of Rp141,665 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PT Medikaloka Hermina Tbk.
Is PT Medikaloka Hermina Tbk's Other Current Liabilities too high?
PT Medikaloka Hermina Tbk's current Other Current Liabilities is Rp141,665 Mil. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Other Current Liabilities compare to HCA and THC?
PT Medikaloka Hermina Tbk's Other Current Liabilities of Rp141,665 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Healthcare Providers & Services company?
A good Other Current Liabilities depends on the Healthcare Providers & Services industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PT Medikaloka Hermina Tbk. PT Medikaloka Hermina Tbk's current Other Current Liabilities is Rp141,665 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,561.68, compared to a current price of Rp690.00 — trading 55.8% below its estimated fair value. The current Other Current Liabilities is Rp141,665 Mil. PT Medikaloka Hermina Tbk's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Other Current Liabilities is Rp141,665 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp690.00 is trading 55.8% below its estimated GF Value™ of Rp1,561.68.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Other Current Liabilities: Rp141,665 Mil
GF Value™: Rp1,561.68 vs. price of Rp690.00 (55.8% below fair value)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
67GF Score
Get the complete analysis for ISX:HEAL
Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
